Study design
Allocation concealment vs blinding: two protections at different times
Allocation concealment prevents upcoming assignments from influencing enrollment; blinding limits knowledge after assignment. Confusing the two can make a trial appear better protected than its actual process supports.
Educational content only. Not medical advice.
Concealment operates before and at assignment
Allocation concealment prevents the person enrolling a participant from knowing the next group before eligibility and consent are finalized. Central randomization or a secure automated system can provide this separation. If upcoming assignments are visible or predictable, recruiters may consciously or unconsciously delay, accelerate, or redirect enrollment, undermining the randomized comparison.
Blinding operates after assignment
Blinding concerns who knows the assigned group during intervention delivery, follow-up, outcome assessment, adjudication, or analysis. A trial may conceal allocation perfectly yet be open-label afterward. It may also use an apparently blinded intervention while recruiters could foresee the sequence. The protections answer different bias pathways and must be reported separately.
Predictability is the central concealment threat
Open assignment lists, alternation, dates, record numbers, transparent block patterns, or poorly controlled envelopes can expose the next allocation. An envelope method is credible only when safeguards prevent advance opening, replacement, tampering, or reading through the material. A paper should describe the mechanism and implementation rather than use the word randomized as a complete account.
Appraise sequence, concealment, and masking as a chain
Ask who generated the sequence, who enrolled participants, who assigned groups, what each person could see, and when codes were released. Then examine post-assignment masking and participant flow. Strong random sequence generation cannot rescue foreknowledge during enrollment, while perfect concealment cannot prevent later measurement bias if susceptible outcomes are assessed with assignment known.
Evidence limits
- Reports often omit operational detail needed to judge concealment confidently.
- Adequate concealment does not guarantee successful post-assignment masking.
- This guide does not certify a particular randomization vendor or envelope process.
Sources and further reading
These sources ground the definitions and evidence boundaries on this page. A citation is a route for verification, not an endorsement of a product or personal use.
Cochrane Handbook for Systematic Reviews of Interventions
Assessing Risk of Bias in a Randomized Trial
Authoritative methods guidance on randomization, allocation concealment, deviations, missing outcomes, measurement, and selective reporting.
Open sourcePubMed Central
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials
Peer-reviewed reporting guideline for randomization, allocation, masking, participant flow, outcomes, and analysis populations.
Open sourceU.S. Food and Drug Administration / ICH
E6(R3) Good Clinical Practice Guidance for Industry
Official good-clinical-practice principles for trial design, conduct, randomization, masking, records, and participant protection.
Open sourceCommon questions
Can an open-label trial have good allocation concealment?
Yes. Enrollment can be protected before assignment even when participants and investigators know the group afterward.
Is a random-number table enough?
It can generate a valid sequence, but the upcoming assignments must also remain concealed from recruiters.
Why does concealment matter if baseline groups look balanced?
A balanced table cannot prove that enrollment was protected from foreknowledge or selective entry.
Continue with context
Keep building your evidence-reading skills
Explore the public PeptideSchool research library for more source-backed methods, glossaries, and evidence maps.